ARID1A

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA005456

Antibody CAB016334

Tissue

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Moderate to strong nuclear immunoreactivity was observed in most malignant cells. A majority of hepatocellular carcinomas, breast, ovarian, renal and gastric cancer were weakly stained or negative. Malignant cells exhibited moderate to strong nuclear immunoreactivity accompanied with membranous staining.

Literature conformity

Consistent with extensive gene/protein characterization dataConsistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected